Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SHR-1210”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03817658
What this trial is testing

A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 725
Early research (Phase 1)Study completedNCT03945604
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC

Who this might be right for
Triple Negative Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 32
Testing effectiveness (Phase 2)Ended earlyNCT03711279
What this trial is testing

SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Jiangsu HengRui Medicine Co., Ltd. 99
Early research (Phase 1)Ended earlyNCT05799183
What this trial is testing

A SHR-1210 BE Study on Healthy Subjects

Who this might be right for
Advanced Tumors
Jiangsu HengRui Medicine Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT03472365
What this trial is testing

SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer

Who this might be right for
Gastric CancerGastroEsophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 67
Testing effectiveness (Phase 2)Ended earlyNCT03666728
What this trial is testing

SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC

Who this might be right for
Lung Neoplasms
Jiangsu HengRui Medicine Co., Ltd. 5
Testing effectiveness (Phase 2)UnknownNCT03603756
What this trial is testing

SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Chinese Academy of Medical Sciences 45
Testing effectiveness (Phase 2)Ended earlyNCT03777124
What this trial is testing

Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer

Who this might be right for
NSCLC Stage IVKRAS Gene MutationPD-1 Antibody+1 more
Jiangsu HengRui Medicine Co., Ltd. 25
Testing effectiveness (Phase 2)UnknownNCT04108013
What this trial is testing

SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC

Who this might be right for
Lung Cancer Stage IIPD-1 AntibodyNon-small Cell Lung Cancer
Xuanwu Hospital, Beijing 38
Testing effectiveness (Phase 2)UnknownNCT04126993
What this trial is testing

Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma

Who this might be right for
Sarcoma
Tianjin Medical University Cancer Institute and Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT04299581
What this trial is testing

Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University 25
Large-scale testing (Phase 3)Study completedNCT03813784
What this trial is testing

A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy

Who this might be right for
Gastric CancerGastroEsophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 885
Early research (Phase 1)Study completedNCT03121716
What this trial is testing

Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 23
Testing effectiveness (Phase 2)UnknownNCT03601598
What this trial is testing

A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC

Who this might be right for
CRCHCCNSCLC
Harbin Medical University 41
Large-scale testing (Phase 3)UnknownNCT03605706
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment.

Who this might be right for
Advanced Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 396
Testing effectiveness (Phase 2)UnknownNCT03363555
What this trial is testing

SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Jiangsu HengRui Medicine Co., Ltd. 97
Testing effectiveness (Phase 2)Study completedNCT03083041
What this trial is testing

SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jiangsu HengRui Medicine Co., Ltd. 210
Not applicableUnknownNCT03722875
What this trial is testing

SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 45
Large-scale testing (Phase 3)Ended earlyNCT04619433
What this trial is testing

Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.

Who this might be right for
Non-squamous Non-small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 48
Testing effectiveness (Phase 2)UnknownNCT04790539
What this trial is testing

SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 71
Next Page